Ad is loading...
HLNCF
Price
$4.47
Change
+$0.05 (+1.13%)
Updated
Nov 15 closing price
SGIOF
Price
$13.71
Change
+$0.84 (+6.53%)
Updated
Nov 15 closing price
Ad is loading...

HLNCF vs SGIOF

Header iconHLNCF vs SGIOF Comparison
Open Charts HLNCF vs SGIOFBanner chart's image
HALEON
Price$4.47
Change+$0.05 (+1.13%)
Volume$3.72K
CapitalizationN/A
Shionogi & Co
Price$13.71
Change+$0.84 (+6.53%)
Volume$300
CapitalizationN/A
HLNCF vs SGIOF Comparison Chart
Loading...
View a ticker or compare two or three
VS
HLNCF vs. SGIOF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLNCF is a Hold and SGIOF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (HLNCF: $4.47 vs. SGIOF: $13.71)
Brand notoriety: HLNCF and SGIOF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HLNCF: 5% vs. SGIOF: 78%
Market capitalization -- HLNCF: $39.92B vs. SGIOF: $12.4B
HLNCF [@Pharmaceuticals: Other] is valued at $39.92B. SGIOF’s [@Pharmaceuticals: Other] market capitalization is $12.4B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLNCF’s FA Score shows that 1 FA rating(s) are green whileSGIOF’s FA Score has 1 green FA rating(s).

  • HLNCF’s FA Score: 1 green, 4 red.
  • SGIOF’s FA Score: 1 green, 4 red.
According to our system of comparison, both HLNCF and SGIOF are a bad buy in the long-term.

Price Growth

HLNCF (@Pharmaceuticals: Other) experienced а -2.40% price change this week, while SGIOF (@Pharmaceuticals: Other) price change was +6.53% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.07%. For the same industry, the average monthly price growth was -7.87%, and the average quarterly price growth was -11.90%.

Industries' Descriptions

@Pharmaceuticals: Other (-5.07% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
HLNCF($39.9B) has a higher market cap than SGIOF($12.4B). HLNCF has higher P/E ratio than SGIOF: HLNCF (27.25) vs SGIOF (9.57). HLNCF YTD gains are higher at: 9.024 vs. SGIOF (-10.993). SGIOF has higher annual earnings (EBITDA): 242B vs. HLNCF (2.06B). SGIOF has more cash in the bank: 563B vs. HLNCF (606M). SGIOF has less debt than HLNCF: SGIOF (9.41B) vs HLNCF (10.4B). SGIOF has higher revenues than HLNCF: SGIOF (427B) vs HLNCF (11.2B).
HLNCFSGIOFHLNCF / SGIOF
Capitalization39.9B12.4B322%
EBITDA2.06B242B1%
Gain YTD9.024-10.993-82%
P/E Ratio27.259.57285%
Revenue11.2B427B3%
Total Cash606M563B0%
Total Debt10.4B9.41B111%
FUNDAMENTALS RATINGS
SGIOF: Fundamental Ratings
SGIOF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
58
PRICE GROWTH RATING
1..100
73
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIDRX8.16-0.01
-0.12%
Lord Abbett International Value R2
NDGIX21.94-0.25
-1.13%
Neuberger Berman Dividend Growth I
IAMOX3.19-0.04
-1.24%
Voya MidCap Opportunities Port A
FNPFX64.73-0.93
-1.42%
American Funds New Perspective F3
JANWX117.41-1.80
-1.51%
Janus Henderson Global Research D

HLNCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLNCF has been loosely correlated with HLN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLNCF jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLNCF
1D Price
Change %
HLNCF100%
+1.13%
HLN - HLNCF
49%
Loosely correlated
+0.86%
SGIOF - HLNCF
21%
Poorly correlated
+6.53%
STEK - HLNCF
11%
Poorly correlated
-4.47%
EAPIF - HLNCF
11%
Poorly correlated
N/A
ZTS - HLNCF
10%
Poorly correlated
+0.29%
More

SGIOF and

Correlation & Price change

A.I.dvisor tells us that SGIOF and AGYTF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SGIOF and AGYTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGIOF
1D Price
Change %
SGIOF100%
+6.53%
AGYTF - SGIOF
25%
Poorly correlated
N/A
HLNCF - SGIOF
21%
Poorly correlated
+1.13%
SFOSF - SGIOF
11%
Poorly correlated
N/A
ROMJF - SGIOF
8%
Poorly correlated
-3.44%
TEVJF - SGIOF
8%
Poorly correlated
-8.21%
More